Cyclin-dependent kinase (CDK) 4/6 inhibitors in combination with endocrine therapy (ET) are considered the standard-of-care treatment for patients with hormone receptor-positive (HR+) human epidermal growth factor receptor 2 (HER2)-negative (-) advanced breast cancer (ABC). The latest developments in the treatment of this cancer were covered during the European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, from 28th–29th September 2019.
EMJ Oncology 8 [Supplement 2] . 2020
Latest articlesAll articles
A Review of the Latest Advancements in Ovarian Cancer Care Featured at ESMO 2022
Ovarian cancer is the seventh most commonly diagnosed cancer among females and the most lethal gynaecologic malignancy globally because of its vague presentation, insidious nature, recurrence, and drug resistance.
Marantic Endocarditis and Lung Adenocarcinoma with Brain Metastasis: A Diagnostic Conundrum
Non-bacterial endocarditis (also known as marantic endocarditis), a term coined by Gross and Fiedberg in 1936, encompasses the non-infectious (sterile) vegetations on structurally normal or superficially damaged cardiac valves in the absence of blood stream infection. Studies have postulated that local physical damage or cytokine mediated damage leads to platelet consumption, activation of clotting factors, and interlacing of fibrin strands that could be contributing to the vegetation formation.
The Role of Radical Radiotherapy in Sinonasal Myopericytoma: A Case Report and Literature Overview
Myopericytoma (previously defined haemangiopericytoma) is a rare vascular tumour originating from extracapillary cells called pericytes and rarely occurs in paranasal sinuses. Surgical wide resection is the treatment of choice. Post-operative radiotherapy is usually used in the case of incomplete resection.